Global Performance Enhancing Drugs Market, By Type (Ergogenic Aids, Nootropic and Others), Products (Pills, Injections, Patches and Others), End User (Athletes, Body Builders, Students, Militaries and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Performance Enhancing Drugs Market
Data Bridge Market Research analyses that the performance enhancing drugs market will exhibit a CAGR of around 5.30% for the forecast period of 2022-2029. Rising prevalence of chronic diseases and disorders, increased focus on research and development proficiencies, growing adoption of advanced healthcare technologies, rising use of anabolic steroids amongst the target audience and patients having medical histories and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of performance enhancing drugs market.
From the name itself, it is clear that performance enhancing drugs that are consumed o improve the athletic performance. Performance enhancing drugs serve as steroids that help to give the consumers a physical edge over others in terms of performance.
Upsurge in the number of athletes is one of the major factors fostering the growth of the market. Rising utilization of performance enhancement drugs to treat various disease conditions is another market growth determinant. Ever- rising popularity of anabolic steroids among general people and rising participation of individuals in weighting and stamina based sports will further generate lucrative market growth opportunities.
However, side effects and health risks associated with the consumption of such drugs will derail the market growth rate. Also, higher risk of heart attacks, risk of cardiovascular diseases and masculinization issue in females will further pose challenges for the market. Further, reduced sperm production in males will also hamper the market growth rate.
This performance enhancing drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on performance enhancing drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Performance Enhancing Drugs Market Scope and Market Size
The performance enhancing drugs market is segmented on the basis of type, products and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the performance enhancing drugs market has been segmented as ergogenic aids, nootropic and others. Ergogenic aids can be further segmented into anabolic steroids, dehydroepiandrosterone (DHEA), human growth hormone and others. Nootropic can be further segmented into racetams, ampakines, choline and acetylcholine intermediates and others
- On the basis of products, the performance enhancing drugs market has been segmented as pills, injections, patches and others.
- Performance enhancing drugs market has also been segmented on the basis of end user into athletes, body builders, students, militaries and others.
Performance Enhancing Drugs Market Country Level Analysis
The performance enhancing drugs market is analysed and market size insights and trends are provided by country, type, products and end user as referenced above.
The countries covered in the performance enhancing drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the performance enhancing drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, presence of developed economies as well as high per capita income. In addition, rising cases of breast cancer which can be cured by certain performance enhancing drugs are further propelling the growth in the region.. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector, rising number of athletes and rising personal disposable income.
The country section of the performance enhancing drugs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The performance enhancing drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for performance enhancing drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the performance enhancing drugs market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Performance Enhancing Drugs Market Share Analysis
The performance enhancing drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to performance enhancing drugs market.
Some of the major players operating in the performance enhancing drugs market report are Taj Pharmaceuticals Limited., Balkan Pharmaceuticals, Bayer AG, AstraZeneca, Novo Nordisk A/S, BrainAlert, LLC, Douglas Laboratories, Onnit Labs, Inc., Tridev Samrath Ayurveda., CIPZER, A.M.Nutratech Pvt. Ltd., Kumar Enterprises, Kumar Enterprises, Conch Healthcare (P) Limited and Eli Lilly And Company among others.
SKU-